Skip Ribbon Commands
Skip to main content
Skip to main navigation Skip to main content
Sign In
Restrict your results by using the refiners below:

​​​​​​​​​​​​​​​​​​​​​Narrow Your Results:​



AUTH/2716/5/14 - Voluntary admission by Napp 338831/03/2016 09:42:03Case number:AUTH/2716/5/14 Case ref:Voluntary admission by Napp Description:Conduct of any evidence to indicate that the complainant was the senior palliative care clinician STS_ListItem_PublishingPages 09:42:03htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
AUTH/2261/9/09 - Voluntary admission by Merck Sharp & Dohme144118/12/2009 11:45:43The action to be taken in relation to a voluntary admission by a company was set out in Paragraph 5.4 STS_ListItem_DocumentLibrary 11:45:43pdfFalsepdf1515~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_PDF.js
2529 Feb 20135207114/03/2013 15:37:32he/she was surprised by the ruling in Case AUTH/2473/1/12 wherein Vifor made a voluntary admission and was, in the complainant’s opinion, treated leniently and ruled in STS_ListItem_DocumentLibrary 15:37:32pdfFalsepdf1515~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_PDF.js
AUTH/2529/9/12 - GP/Director v Vifor – Breach of undertaking323506/06/2014 14:17:27Having read that case report, the complainant now asked for the breach of undertaking to not subject of a complaint or a voluntary admission and nor was there any mechanism under STS_ListItem_PublishingPages 14:17:27htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
2641 Nov 2013163811/12/2013 10:00:36COMPLAINT The complainant noted that a number of prescribers in the trust had received the promotional email at issue; the complainant noted that Cipralex was not on the trust STS_ListItem_DocumentLibrary 10:00:36pdfFalsepdf1515~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_PDF.js
Bayer HealthCare named in advertisements for breaches of the ABPI Code of Practice 108812/09/2012 14:57:09Bayer made a voluntary admission in relation to the distribution of unapproved documents Both the complainant and the respondent company may appeal to the Code of Practice Appeal STS_ListItem_PublishingPages 14:57:09htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
2018 February Review80809/04/2018 12:27:28NUMBER 99 February 2018 CODE OF PRACTICE Director, of which 6 arose from voluntary admissions by companies, a substantial decrease on 2016, when there were 13 voluntary admissions STS_ListItem_DocumentLibrary of Practice Reviews/Forms/AllItems.aspx0 12:27:28pdfFalsepdf1515~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_PDF.js
Shire Pharmaceuticals Ltd and Roche Products Limited named in advertisements for breaches of the ABPI Code of Practice.112924/05/2013 13:40:34Voluntary admission by Roche – Case AUTH/2582/2/13 Roche made a voluntary admission in relation to the distribution of an STS_ListItem_PublishingPages 13:40:34htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
AUTH/2593/4/13 - Genzyme v Shire328206/06/2014 14:17:32company might not have included in that admission an adequate description of the breach of off inter-company dialogue on the matter stating that it would make a ‘voluntary admission STS_ListItem_PublishingPages 14:17:32htmlFalseaspx1616~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_WebPage.js
AUTH/2326/6/10 - Consultant Haematologist v Bayer Schering Pharma122214/12/2010 11:07:43In particular, the complainant knew about one patient who felt a gross breach of Bayer Schering Pharma made a voluntary admission regarding an envelope (ref UK.PH.HN.KOG 2010.15 STS_ListItem_DocumentLibrary 11:07:43pdfFalsepdf1515~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_PDF.js

Restrict your results by using the refiners below:
Related links